2004
DOI: 10.1016/j.phrs.2003.12.004
|View full text |Cite
|
Sign up to set email alerts
|

Pharmacokinetics and pharmacodynamics of safinamide, a neuroprotectant with antiparkinsonian and anticonvulsant activity

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

11
104
0

Year Published

2012
2012
2022
2022

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 102 publications
(116 citation statements)
references
References 8 publications
11
104
0
Order By: Relevance
“…Hence, it becomes necessary to determine the bioavailability of the tested chemicals. In the present study, we calculated the maximum concentration (C max ) test species is actually exposed (Marzo et al 2004). This could help us in determining an approximate value for both bioavailability and effective range of a particular chemical to the test organism, as pointed by Saghir et al (2006).…”
Section: Edc Toxicity On C Polykrikoidesmentioning
confidence: 99%
“…Hence, it becomes necessary to determine the bioavailability of the tested chemicals. In the present study, we calculated the maximum concentration (C max ) test species is actually exposed (Marzo et al 2004). This could help us in determining an approximate value for both bioavailability and effective range of a particular chemical to the test organism, as pointed by Saghir et al (2006).…”
Section: Edc Toxicity On C Polykrikoidesmentioning
confidence: 99%
“…Chemically, Safinamide is (S)-(+)-2-[4-(3-fluorobenzyloxybenzylamino) propanamide] methane sulfonate (1 : 1 salt) ( Figure 1) [1,2].…”
Section: Introductionmentioning
confidence: 99%
“…Some anticonvulsants like lamotrigine and zonizamide are effective against MES, preventing tonic clonic seizures in man and displaying inhibitory effects against MAO-B (Muck-Seler et al, 2008;Sonsalla et al, 2010). This property suggests a neuroprotective effect due to a reduction in reactive oxygen species generated in the central nervous system by this enzyme, a characteristic that could be of special interest in searching for modern anticonvulsant drugs (Marzo et al, 2004). MAO inhibition has been described as a possible anticonvulsant mechanism of action of some agents.…”
Section: Discussionmentioning
confidence: 99%